179 related articles for article (PubMed ID: 10190077)
1. Ukrain (NSC-631570) in experimental and clinical studies: a review.
Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
[TBL] [Abstract][Full Text] [Related]
2. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
3. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
[TBL] [Abstract][Full Text] [Related]
4. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
Cordes N; Plasswilm L; Bamberg M; Rodemann HP
Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
[TBL] [Abstract][Full Text] [Related]
5. Ukrain both as an anti cancer and immunoregulatory agent.
Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas.
Nowicky JW; Staniszewski A; Zbroja-Sontag W; Slesak B; Nowicky W; Hiesmayr W
Drugs Exp Clin Res; 1991; 17(2):139-43. PubMed ID: 1713821
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain).
Staniszewski A; Slesak B; Kołodziej J; Harłozińska-Szmyrka A; Nowicky JW
Drugs Exp Clin Res; 1992; 18 Suppl():63-7. PubMed ID: 1305047
[TBL] [Abstract][Full Text] [Related]
8. Ukrain: a novel antitumor drug.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma.
Voltchek IV; Liepins A; Nowicky JW; Brzosko WJ
Drugs Exp Clin Res; 1996; 22(3-5):283-6. PubMed ID: 8899349
[TBL] [Abstract][Full Text] [Related]
10. Action of Ukrain, a cytostatic and immunomodulating drug, on effects of irradiation.
Boyko VN; Voltchek IV; Petrov AS; Bubnov VP
Drugs Exp Clin Res; 1996; 22(3-5):167-71. PubMed ID: 8899323
[TBL] [Abstract][Full Text] [Related]
11. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
[TBL] [Abstract][Full Text] [Related]
12. Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during short-term gamma-irradiation.
Luksa-Lichtenthaeler GL; Ladutko EI; Nowicky JW
Drugs Exp Clin Res; 2000; 26(5-6):311-5. PubMed ID: 11345044
[TBL] [Abstract][Full Text] [Related]
13. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570).
Liepins A; Nowicky JW; Bustamante JO; Lam E
Drugs Exp Clin Res; 1996; 22(3-5):73-9. PubMed ID: 8899308
[TBL] [Abstract][Full Text] [Related]
14. A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation.
Boyko VN; Zholus RB
Drugs Exp Clin Res; 1998; 24(5-6):331-3. PubMed ID: 10190098
[TBL] [Abstract][Full Text] [Related]
15. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
[TBL] [Abstract][Full Text] [Related]
16. Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report).
Steinacker J; Kroiss T; Korsh OB; Melnyk A
Drugs Exp Clin Res; 1996; 22(3-5):275-7. PubMed ID: 8899347
[TBL] [Abstract][Full Text] [Related]
17. Six-week treatment with Ukrain in rabbits. Part III: Serum levels of thyroid hormones.
Jagiello-Wójtowicz E; Kleinrok Z; Feldo M; Chodkowska A; Szklarczyk V; Urbanska EM
Drugs Exp Clin Res; 1998; 24(5-6):305-8. PubMed ID: 10190092
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
Sotomayor EM; Rao K; Lopez DM; Liepins A
Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
[TBL] [Abstract][Full Text] [Related]
19. Influence of Ukrain on patients with surgically treated breast cancer. Part I. Clinical and laboratory parameters.
Uglyanica KN; Fomin KA; Nefyodov LI; Nowicky JW; Brzosko WJ; Jankowski A
Drugs Exp Clin Res; 1996; 22(3-5):135-8. PubMed ID: 8899316
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic properties of Ukrain (NSC-6315170) on human peripheral blood monocytes: clinical implications.
Jin YM; Nowicky JW; Liepins A
Drugs Exp Clin Res; 1996; 22(3-5):99-101. PubMed ID: 8899311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]